Fluvirucin A1

N/A

Report date: 2023/06/26 09:16:01
NME

Base Information

Drug NameFluvirucin A1
Drug Alias NameN/A
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionBeta Lactamase modulators
TargetsBeta Lactamase
Therapy Area/IndicationsVirus DiseasesInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBristol-Myers Squibb Company
Active IndicationsN/A
Inactive IndicationsVirus DiseasesInfluenza, Human

Other Information

ATC CodeN/A
Related LinksN/A